{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T17:09:13Z","timestamp":1763831353730,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid malignancy and also has an excellent prognosis. Primary thyroid lymphoma (PTL) is rare and has a poor prognosis. The co-occurrence of both malignancies is extremely rare, and the preoperative diagnosis is rather difficult. We report the case of a patient with both PTC and PTL in the setting of Hashimoto\u2019s thyroiditis (HT). A 59-year-old female patient was referred to our department for progressive enlargement of the thyroid gland over a few months. The imaging results demonstrated an enlarged thyroid and a mass in the thyroid. Total thyroidectomy and bilateral central neck node dissection were conducted. The final diagnosis of the coexistence of thyroid diffuse large B cell lymphoma and PTC was confirmed by histopathology and immunohistochemistry. The patient received radiation therapy and six cycles of chemotherapy combined with targeted therapy, including rituximab, cyclophosphamide, doxorubicin, vindesine, and prednisone (R-CHOP). After 6 months of follow-up, neither tumor has recurred. It is important for physicians to keep PTL in mind for differential diagnosis in HT patients with sudden thyroid enlargement.<\/jats:p>","DOI":"10.3389\/fonc.2023.1248830","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T13:20:57Z","timestamp":1696512057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Coexistence of primary thyroid diffuse large B cell lymphoma and papillary thyroid carcinoma in a patient with Hashimoto\u2019s thyroiditis: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Juncheng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengdong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp050","article-title":"Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution","volume":"20","author":"Sciuto","year":"2009","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31805375ca","article-title":"Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients","volume":"32","author":"Pelizzo","year":"2007","journal-title":"Clin Nucl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1064050","article-title":"Primary thyroid lymphoma: A single-center experience","volume":"14","author":"Lee","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","article-title":"Primary thyroid lymphoma","volume":"26","author":"Ansell","year":"1999","journal-title":"Semin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1387","article-title":"Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre","volume":"40","author":"Alzouebi","year":"2012","journal-title":"Int J Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1015-9584(10)60004-8","article-title":"Primary lymphoma of the thyroid: diagnostic and therapeutic considerations","volume":"33","author":"Sarinah","year":"2010","journal-title":"Asian J Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1428","article-title":"Primary thyroid lymphoma: a clinical review","volume":"98","author":"Stein","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2010.06.006","article-title":"Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily","volume":"71","author":"Rizzo","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.801925","article-title":"Hashimoto's thyroiditis: A \"Double-edged sword\" in thyroid carcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08606.x","article-title":"Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease","volume":"153","author":"Watanabe","year":"2011","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.971249","article-title":"Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis","volume":"13","author":"Vander Poorten","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/1596-3519.117632","article-title":"A rare coexistence of thyroid lymphoma with papillary thyroid carcinoma","volume":"12","author":"Cakir","year":"2013","journal-title":"Ann Afr Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23917","article-title":"Primary thyroid diffuse large B-cell lymphoma coexistent with papillary thyroid carcinoma: A case report","volume":"37","author":"Xie","year":"2015","journal-title":"Head Neck"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000313","article-title":"Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis","volume":"61","author":"Trovato","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/JOC.JOC_180_15","article-title":"Cytodiagnosis of primary thyroid lymphoma coincident with unnoticed papillary thyroid carcinoma: A case report and review of the literature","volume":"35","author":"Kir","year":"2018","journal-title":"J Cytol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519869133","article-title":"Coexistence of primary thyroid diffuse large B cell lymphoma and papillary thyroid carcinoma: a case report and literature review","volume":"47","author":"Chen","year":"2019","journal-title":"J Int Med Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.570","article-title":"Synchronous primary diffuse large B-cell lymphoma and papillary thyroid carcinoma: A case report highlighting \"Lymphoma first approach\"","volume":"71","author":"Dhanani","year":"2021","journal-title":"J Pak Med Assoc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0672","article-title":"Fine-needle aspiration to diagnose primary thyroid lymphomas: a systematic review and meta-analysis","volume":"180","author":"Zhang","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01712-3","article-title":"Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort","volume":"45","author":"Zhu","year":"2022","journal-title":"J Endocrinol Invest"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1248830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T13:21:00Z","timestamp":1696512060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1248830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":20,"alternative-id":["10.3389\/fonc.2023.1248830"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1248830","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"article-number":"1248830"}}